global presence
Local support from a global company
Huvepharma® has a distribution network which covers more than 90 countries in 6 continents. Find your nearest Huvepharma® representative today.
Find your local contact
- Change country
Eradication Of Mycoplasma Hyopneumoniae Based Upon Partial Depopulation And Strategic Medication
Poster | 16.08.2023
Poster presented by Lieven Claerhout at ESPHM 2023 in Thessaloniki, Greece.
Reducing the infection pressure in a pig unit is vital to ensure the health of the herd. In this trial, Mycoplasma hyopneumoniae was successfully eradicated using a combination of partial depopulation (fattening and weaning units) plus strategic medication of sows using Vetmulin.
Download poster
You might also find this interesting
Article | 03.04.2023
Vetmulin® / Rodotium® (Tiamulin): An Excellent Choice for the Treatment of Mycoplasma-induced Arthritis
Article | 14.06.2023
How To Manage Mycoplasma-Induced Arthritis
Article | 15.03.2023
Eradication of Mycoplasma hyopneumoniae by partial depopulation and strategic medication with Vetmulin® / Rodotium® (Tiamulin)
Article | 14.04.2023
Efficacy of Vetmulin® / Rodotium® (Tiamulin) in Controlling Mycoplasma Suis Infections
about us
Huvepharma®
Huvepharma® is a fast-growing, global pharmaceutical company with a focus on developing, manufacturing and marketing human and animal health and nutrition products.
more about us
Change country
The Huvepharma® distribution network covers 90 countries in 6 continents. Please select a country from the list below to see the products and services available in that region.
To view all products and services, select Global from the dropdown menu or click .
Change language
Huvepharma has a remarkable distribution network which covers 90 countries in 6 continents. To offer you the best services, we ask you to select your country.
Europe
top
Your browser is out of date!
Update your browser to view this website correctly. Update my browser now